The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme FAAH (FAAH rs2295633) with attention deficit hyperactivity disorder - Ahmadalipour, A; Mehdizadeh Fanid, L; Zeinalzadeh, N (Genomics, 2020)
et al.